首页|利用斑马鱼模型和网络药理学研究荷丹胶囊血管保护作用的主要活性成分

利用斑马鱼模型和网络药理学研究荷丹胶囊血管保护作用的主要活性成分

扫码查看
目的 利用斑马鱼模型和网络药理学方法研究荷丹胶囊的血管保护作用主要活性成分,为后续深入研究提供科学依据。方法 采用血管转基因标记的CZ55系斑马鱼为实验动物,评价荷丹胶囊对斑马鱼血管损伤的保护作用;通过中医药整合药理学研究平台TCMIP、TCMSP、Gencards数据库、String平台、Cytoscape软件构建荷丹胶囊中荷叶、丹参、山楂、番泻叶、补骨脂的主要化学成分与作用靶点的相互作用网络,并筛选中药活性成分,同时利用分子对接进行成分与靶点结合能评价,然后采用斑马鱼模型对筛选的活性成分进行二次验证。结果 斑马鱼实验结果显示荷丹胶囊具有显著保护血管内皮损伤的作用;网络药理学筛选和分子对接结果提示丹参酮Ⅱ A、荷叶碱、补骨脂异黄酮醛、槲皮素可能是荷丹胶囊发挥药效的重要物质基础;斑马鱼实验结果显示,丹参酮Ⅱ A、槲皮素具有明显的血管保护活性。结论 荷丹胶囊中丹参酮ⅡA、槲皮素可能是发挥血管保护作用的重要物质基础,具有多靶点整合调节的作用特点。
Zebrafish model and network pharmacology platform were used to study the main active components of Hedan capsule for vascular protection
Objective To study the main active components of Hedan capsule by zebrafish model and network pharmacology method,and to provide reference for its clinical application.Methods CZ55 line zebrafish was used as experimental animals to evaluate the protective effect of Hedan capsule on drug-induced vascular injury.Through TCMIP,TCMSP,Gencards database,String platform and Cytoscape software,the interaction network of main chemical components and targets of Hedan capsule was constructed.Furthermore,the active components of traditional Chinese medicine were screened,and the binding energy of components to target was evaluated by molecular docking.Then the zebrafish model was used to validate the active components.Results The results of zebrafish experiment show that Hedan capsule has a significant protective effect on vascular endothelial injury.The network pharmacology screening and molecular docking suggested that tanshinone ⅡA,nuciferine,corylinal and quercetin might be the important material basis for the efficacy of Hedan capsule.The results of zebrafish experiment showed that tanshinoneⅡA and quercetin had obvious vascular protective activity.Conclusion Tanshinone ⅡA and quercetin in Hedan capsule might be the important material basis of vascular protection,and have the characteristics of multi-target integrated regulation.

Hedan capsulenetwork pharmacologyvascular protectionzebrafish

王娜、王喆、张杨腾皎、王哲哲、王松松、张友刚、曾英姿、傅春升、韩利文

展开 >

山东中医药大学药学院,山东济南 250000

山东第一医科大学药学与制药科学学院,山东济南 250000

山东沃华医药科技股份有限公司,山东潍坊 261000

荷丹胶囊 网络药理学 血管保护 斑马鱼模型

中央本级重大增减支项目山东省自然科学基金山东第一医科大学学术提升计划

2060302-1907-09ZR2019MH0372019LJ003

2024

沈阳药科大学学报
沈阳药科大学

沈阳药科大学学报

CSTPCD
影响因子:0.604
ISSN:1006-2858
年,卷(期):2024.41(2)
  • 25